Inspira Technologies unveils modular VORTX blood oxygenation tech
Ticker: IINNW · Form: 6-K · Filed: Jan 14, 2025 · CIK: 1837493
| Field | Detail |
|---|---|
| Company | Inspira Technologies Oxy B.H.N. LTD (IINNW) |
| Form Type | 6-K |
| Filed Date | Jan 14, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: product-update, medical-technology, innovation
TL;DR
Inspira unveils modular VORTX oxygenation tech, aiming for better patient care & efficiency.
AI Summary
On January 14, 2025, Inspira Technologies Oxy B.H.N. Ltd. announced a new modular configuration for its VORTX blood oxygenation delivery technology. This innovation aims to enhance the adaptability and efficiency of their medical device.
Why It Matters
This modular design could improve patient care by allowing for more tailored oxygenation delivery and potentially reduce manufacturing costs for Inspira's innovative medical technology.
Risk Assessment
Risk Level: low — This filing is an informational update regarding product development and does not appear to involve significant financial transactions or immediate operational changes.
Key Players & Entities
- Inspira Technologies Oxy B.H.N. Ltd. (company) — Registrant
- VORTX (product) — Blood Oxygenation Delivery Technology
- January 14, 2025 (date) — Date of press release
FAQ
What is the primary purpose of the new modular configuration for the VORTX technology?
The press release indicates the modular configuration is designed to enhance the adaptability and efficiency of the VORTX blood oxygenation delivery technology.
What is the name of the technology being updated by Inspira Technologies?
The technology being updated is the VORTX blood oxygenation delivery technology.
When was the press release announcing this update issued?
The press release was issued on January 14, 2025.
What type of company is Inspira Technologies Oxy B.H.N. Ltd.?
Inspira Technologies Oxy B.H.N. Ltd. is a foreign private issuer in the Surgical & Medical Instruments & Apparatus industry.
What form is this filing submitted under?
This filing is submitted as a Form 6-K, Report of Foreign Private Issuer.
Filing Stats: 303 words · 1 min read · ~1 pages · Grade level 10.1 · Accepted 2025-01-14 16:10:24
Filing Documents
- ea0227585-6k_inspira.htm (6-K) — 11KB
- ea022758501ex99-1_inspira.htm (EX-99.1) — 9KB
- 0001213900-25-003417.txt ( ) — 22KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inspira Technologies Oxy B.H.N. Ltd. Date: January 14, 2025 By: /s/ Dagi Ben-Noon Name: Dagi Ben-Noon Title: Chief Executive Officer 2